Promising early data details on Amgen weight-loss drug published | Reuters
News | Amgen
Scott Skellenger on LinkedIn: #brainstormai #mycompany
Amgen | A Worldwide Pioneer in Biotechnology
Syngene International Limited - We are delighted to share that Syngene has extended its ongoing long-standing multi-discipline research collaboration with Amgen Inc until 2026. Under the extended contract, the dedicated R&D center, '
Amgen To Present At The Credit Suisse 25th Annual Healthcare Conference | World Pharma Today
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Le Fonds Amgen France pour la Science et l'Humain confirme son engagement contre le cancer et lance son 3e appel à projets en oncologie et onco-hématologie
MilaQuebec on X: "Mila is pleased to announce the expansion of its partnership with @Amgen, one of the world's leading biotechnology companies. Press release 👉 https://t.co/zp6eD9y5KD https://t.co/NSLtAnuEH9" / X
SSG Advises Unilife Corporation in the Sale of its Assets to OrbiMed and Amgen – SSG Capital Advisors, LLC
Amgen Announces Launch Of New Neulasta® (Pegfilgrastim) Delivery Kit
Amgen cuts lupus programs for futility
Amgen Makes Repatha® (Evolocumab) Available In The US At A 60 Percent Reduced List Price| Amgen
Innovation | Amgen
Amgen Partners of Choice
Amgen France s'engage pour plus d'équité et d'inclusion au travail en lançant sa campagne Diversité
Newsroom | Amgen
Leader mondial des biotechnologies - Amgen France
Amgen Joins American Kidney Fund's 2023 Corporate Membership Program at 'Champion' Level | American Kidney Fund
The Amgen Inc (AMGN) Company: A Short SWOT Analysis
Amgen France s'engage pour plus d'équité et d'inclusion au travail en lançant sa campagne Diversité
AMGEN PROVIDES LONG-TERM GUIDANCE THROUGH 2030 DURING BUSINESS REVIEW MEETING| Amgen
News Release
News | Amgen
FTC Pauses Challenge to Amgen's $27.8 Billion Deal for Horizon Therapeutics - WSJ
